Share Price:

APNASPENAspen Pharmacare Hldgs18560-330 (-1.75%)

Aspen increases revenue 16% to R41.2 bn

Johannesburg – JSE Limited listed Aspen Pharmacare Holdings Limited (APN), a leading global pharmaceutical company, has announced pleasing results for the year ended 30 June 2017.

Download (PDF 86.7KB)


Closed Period

Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.